http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20031696

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 1059
issn 0090-4295
issueIdentifier 5
pageRange 1054-1059
publicationName Urology
startingPage 1054
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b711ffdbe8af5c8f3f9c53da46d83fa
bibliographicCitation Polascik TJ, Given RW, Metzger C, Julian SR, Vestal JC, Karlin GS, Barkley CS, Bilhartz DL, McWhorter LT, Lacerna LV. Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases. Urology. 2005 Nov;66(5):1054–9. doi: 10.1016/j.urology.2005.05.035. PMID: 16286123.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fc88ee13d0719aad73fd89cf746b583
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_677d6afb2b35af798751c766706a9516
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b49e5ae1bad96b9c27bdc4bb7114284e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65c021e9f0f0aeecbc94ddfc61a1429f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9689c0e2f9f6179391c422bbd56c45bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c133f8a0d2c5353420de9c056fc3f34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05b2081511e8f01f8653db702d347ae6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8898b688f9a3aacc786861aa1ac5c190
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff00d2092bee9571b96168cb47a05f4a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_214e51c6a5232d3cb130881ed262d7b2
date 200511
identifier https://pubmed.ncbi.nlm.nih.gov/16286123
https://doi.org/10.1016/j.urology.2005.05.035
isPartOf https://portal.issn.org/resource/ISSN/0090-4295
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7907
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases
discusses http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0006519
http://id.nlm.nih.gov/mesh/M0234600
http://id.nlm.nih.gov/mesh/M0472480
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7008
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.3.1

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 45.